GENE ONLINE|News &
Opinion
Blog

National Institute of Allergy and Infectious Diseases
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
Eli Lilly Launches Phase 3 Trial with Baricitinib for COVID-19 Patients
2020-06-26
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
LATEST
Core8 Group and MedArmor to Pioneer Vietnam’s First AI x ESG Hospital
2024-12-10
The Future of Generative AI for New Drug Development and Precision Medicine
2024-12-09
How FIRM is Shaping Regenerative Medicine in Japan
2024-12-09
AI, Smart Tech, and ICT to Unite the Global Biotech and Healthcare Industries in 2025
2024-12-06
Core8 Group to Establish Vietnam’s First Comprehensive Biotechnology Incubator
2024-12-05
Ono Enters into Drug Discovery Collaboration Agreement with Congruence Therapeutics to Generate Novel Small Molecule Correctors in the Oncology Area
2024-12-05
Ipsen Bets $600M on Biomunex’s First-in-Class T-Cell Engager BMX-502
2024-12-03
EVENT
Scroll to Top